Polyethylene Hip Resurfacing to Treat Arthritis and Severe Acetabular Insufficiency.

Journal: The Journal Of Arthroplasty
Treatment Used: Polyethylene Hip Resurfacing
Number of Patients: 232
MediFind Summary

Summary: The study researched the effects of polyethylene hip resurfacing for treating arthritis and severe acetabular insufficiency.

Conclusion: Polyethylene hip resurfacing is safe and effective for arthritis and severe acetabular insufficiency.


Background: Hip dysplasia is the leading cause of hip arthritis in young adults. These patients often participate in active lifestyles that require a full and stable range of motion.

Methods: Between 2001 and 2011, 232 consecutive polyethylene resurfacing arthroplasties were performed in 201 patients with advanced arthritis from severe acetabular insufficiency due to dysplasia. All patients had Crowe II or III disease. Their mean age at surgery was 43 years. A 2-piece cementless acetabular resurfacing shell with dome screws and a highly cross-linked polyethylene liner were implanted to provide secure fixation, early weight bearing, and a stable hip. Additional structural bone grafts and/or fixation were not used. A cemented or cementless resurfacing prosthesis was used on the femur.

Results: During a mean follow-up of 10 years, 8 hips (3.5%) were converted to a total hip arthroplasty due to acetabular loosening (1), femoral neck fracture (2), femoral osteonecrosis (2), infection (2), or persistent pain (1), resulting in a mean survival of the resurfacing prostheses of 96% (95% confidence interval 89-98). There were no pending revisions and no dislocations. At 2 years postoperative, Harris Hip Scores improved from a preoperative mean of 55 to 97 and University of California Los Angeles activity scores improved from 5 to 8.

Conclusion: Hip resurfacing using a 2-piece polyethylene acetabular component for advanced dysplasia has resulted in excellent function and implant survivorship with a low rate of complications at mid-term follow-up.

James Pritchett

Similar Latest Advances